We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities in Medical


Premium OLBERON MEDICAL Medical EIS
Olberon is a UK based medical device innovations company seeking to raise funds for manufacturing and the sale of Vacuderm which is a device designed to assist with childrens cannulation procedure. Olberon Ltd has already got a strong portfolio of patented medical innovations and two medical devices which are market ready.
investment: £5,634 target: £100,000 pre-money valuation: £1,399,250
status: Expired
More Information
6%
Premium DC Surgical Supplies Limited Medical EIS SEIS
Reducing the cost of orthopaedic equipment by using compression screws and titanium maxiangle locking plates. DC Surgical Supplies have acquired an exclusive license with Palmer & Baker with the aim of helping the NHS cut the cost of purchasing regular-use equipment by as much as 35%. Their product is CE Certified and has been featured in The Telegraph.
investment: £99,000 target: £325,000 pre-money valuation: £487,500
status: Expired
More Information
30%
Premium Arcis Biotechnology Medical EIS
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
investment: £1,146,318 target: £999,999 pre-money valuation: £19,202,001
status: Expired
More Information
115%
Premium Aseptium Medical EIS
During their stay in hospital, around 7-10% of patients attract unexpected infections. In some cases, this is caused by unclean complex surgical tools. Aspetium have developed ultrasonic washers (dubbed "uSonic") to thoroughly decontaminate expensive surgical instruments, which can be safely reused to potentially prevent easily avoidable infections.
investment: £150,903 target: £90,009 pre-money valuation: £2,343,452
status: Expired
More Information
168%
Jupiter Diagnostics Medical EIS
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
investment: £2,005,050 target: £2,132,376 pre-money valuation: £1,968,347
94%
Nayanacare Medical EIS SEIS
Nayanacare is a mobile and pc app that allows individual customers to make the right choice of care services and carers quick and easy. Care suppliers can reduce costs by using Nayanacare as a dedicated marketing platform and take advantage of the platforms business management capabilities.
investment: £76,030 target: £150,000 pre-money valuation: £1,350,000
status: Expired
More Information
51%
Ultramed Medical EIS
Ultramed are a health tech company, placing patient experience and innovation at the forefront. They operate a suite of cloud based pre operative products by combining clinical NHS operative experience. The aim is to reduce costs increase health care resources.
investment: £321,240 target: £100,000 pre-money valuation: £466,893
status: Expired
More Information
321%
Combat Medical Medical EIS
Combat Medical have created an innovative method to treat bladder cancer by using heated chemotherapy. By heating the treatment the membrane is more permeable and is able to penetrate further. 
investment: £1,725,220 target: £700,000 pre-money valuation: £20,243,298
status: Funded
More Information
246%
Dentinal Tubules Medical EIS
Providing dental professionals with an online Personal Development Plan for their Continuing Professional Development. Dentinal Tubules currently has more than 2,100 individuals registered to use the service and over 2,700 dental practice professionals that are paying for a subscription. Dentinal Tubules hosts more than 1,500 educational and certified videos to help with a professional's CPD, in addition they also offer live courses, a livestream and an annual congress. Investments will be used to enhance, develop and bring the technology in-house.
investment: £155,820 target: £250,000 pre-money valuation: £2,056,151
status: Expired
More Information
62%
Molecular Warehouse Medical EIS
Molecular Warehouse are trying to create a world where most diseases are prevented by giving people the chance to monitor and manage their helath where ever and whenever. Molecular Warehouse have developed a platform that allows anyone to test themselves at any time.
investment: £420,110 target: £300,000 pre-money valuation: £3,949,292
status: Stretch
More Information
140%
Metrion Biosciences Medical EIS
Metrion Biosciences is a pharmaceutical research organisation that provide a high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis.
investment: £465,150 target: £300,000 pre-money valuation: £1,501,802
status: Expired
More Information
155%
MGB Medical EIS
MGB Biopharma is tackling the worldwide threat of antimicrobial resistance.   The company is in the process of clinical study and designing a new class of antibiotic.  They are looking for investment to start phase 2 of the study with 70% being supported by a grant.
investment: £1,309,621 target: £1,300,000 pre-money valuation: £8,920,126
status: Expired
More Information
101%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph